Skip to content

Sichenzia Ross Ference Carmel LLP Ranks Third Among Securities Law Firms in PlacementTracker’s PIPE and Private Placement Markets League Tables for Q2 2024

Press Release – New York, NY – August 7, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it was ranked third nationally among securities law firms in the Issuer Counsel category for PIPE and private placement markets in Q2 2024. SRFC was also included among the top ten for the category of Placement…

Read More

Sichenzia Ross Ference Carmel LLP Represents Vyome Therapeutics in a Merger Agreement with ReShape Lifesciences

New York, NY – July 11, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Vyome Therapeutics, Inc., a private clinical-stage healthcare company targeting immuno-inflammatory and rare diseases, in connection with the execution of a definitive merger agreement with ReShape Lifesciences Inc, the premier physician-led weight loss and metabolic health-solutions company.  Vyome and ReShape will combine in an all-stock transaction, and…

Read More

Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics Corp. in $5 Million Registered Direct Offering

Press Release – New York, NY – May 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, in a $5 million registered direct offering.  The Company sold an aggregate of 2,402,935 common…

Read More
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.